HRT Financial’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

HRT Financial’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-24,737	Closed	-$406K	–	3365
2023 Q4	$406K	Buy	+24,737	New	+$390K	﹤0.01%	1469
2022 Q2	–	Sell	-2,599	Closed	-$18K	–	3955
2022 Q1	$18K	Buy	+2,599	New	+$25.5K	﹤0.01%	2851
2021 Q4	–	Sell	-2,050	Closed	-$47K	–	4321
2021 Q3	$47K	Buy	+2,050	New	+$61K	﹤0.01%	3056
2021 Q2	–	Sell	-2,316	Closed	-$168K	–	3703
2021 Q1	$168K	Buy	+2,316	New	+$165K	﹤0.01%	2355
2020 Q4	–	Sell	-1,736	Closed	-$71K	–	2628
2020 Q3	$71K	Buy	+1,736	New	+$89.7K	﹤0.01%	1606

HRT Financial's ORTX Position: Q1 2024 in Review

HRT Financial sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 24,737 shares — an estimated $406K sold.

HRT Financial first reported a position in ORTX in Q3 2020 and held it in 5 quarters. The position peaked at $406K in Q4 2023. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

HRT Financial reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
HRT Financial sold 24,737 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $406K.
HRT Financial first reported a position in Orchard Therapeutics plc American Depositary Shares in Q3 2020 and held it in 5 quarters.
HRT Financial's Orchard Therapeutics plc American Depositary Shares position peaked at $406K in Q4 2023.
0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on HRT Financial's 13F filing for Q1 2024, filed 13 May 2024.